CBD’s GRAS status denied: FDA emits further warnings on compound’s legality amid safety concerns

Related Articles

FormattedPicture

BUSINESS NEWS

16 Jun 2021 --- Royal DSM has entered into a commercial partnership with US-based cannabinoid ingredients manufacturer Mile High Labs (MHL) to develop “unique hemp-derived... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Jun 2021 --- Attitudes to CBD are opening up as COVID-19 has brought mental health into greater focus. This is according to Trip’s co-founder Olivia Ferdi, who speaks to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

09 Jun 2021 --- The US Food and Drug Administration (FDA) has released guidance outlining key investments for the nutrition sector within President Biden’s Fiscal Year 2022... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Jun 2021 --- US-based cannabinoid health and wellness company Open Book Extracts (OBX) has closed a US$11.5 million series B funding round. The company will use the financing to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

28 May 2021 --- In nutrition news this week, the Ingredient Transparency Center’s Collagen Stewardship Alliance (CSA) added three major companies to its supporters list. The... Read More

trans